System Maintenance Notice

Please note that maintenance work is scheduled between 4 AM and 5 AM - CET. During this time, you may experience reduced performance. Thanks for your patience.

Massimo Girardis is an expert in Critical care at Policlinico di Modena (Italy). As of October 2026, ScienceLeadR ranks Massimo Girardis in the top 1% of experts worldwide for Critical Illness, Pneumonia and Coronavirus Infections. Massimo Girardis has authored 309 publications, the most recent in 2026, and is an investigator in 19 clinical trials, 3 of them ongoing. SLR score: 1,128 (community average: 125). How the SLR is computed.

LeadR Profile

Massimo Girardis Policlinico di Modena Italy
1 128 ScienceLeadR Reputation 1128

Unlock

Register Login
Network Map

Critical care

Subspecialties: Infectiology - Pulmonology - Public Health

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Organizations

Career arc: 1996 - 2026
Source: PubMed

Policlinico di Modena

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 309

Citations

Citations: 17 937 1st author: 24 Last author: 74 Unique author: 1

Main journals

Intensive Care Med 24
Crit Care 18
J Anesth Analg Crit Care 18
Minerva Anestesiol 16
Transplant Proc 8

Best Journals

Intensive Care Med 4
Lancet Respir Med 4
JAMA 3

Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Phenotype-based appropriateness of IGM-enriched polyclonal immunoglobulin use in critical illness: report of an expert consensus.
PMID 42850671 — shock, septic, phenotype, immunoglobulins, sepsis, critical illness, transplants, therapeutics, infections, immunoglobulins, intravenous		J Anesth Analg Crit Care20260
IgM-Enriched Immunoglobulin As Adjunctive Therapy in Adult Sepsis and Septic Shock: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
PMID 42538732 — language, mortality, shock, septic, immunoglobulins, odds ratio, sepsis, records, therapeutics, immunoglobulins, intravenous		Crit Care Explor20260
Strategies to prevent ventilator-associated pneumonia in critically ill mechanically ventilated patients: a SIAARTI consensus statement.
PMID 42415225 — drainage, epidemiology, pneumonia, ventilator-associated, chlorhexidine, pneumonia, critical illness		J Anesth Analg Crit Care20260
HIgh versus STAndard blood Pressure target in hypertensive high-risk patients undergoing elective major abdominal surgery: the HISTAP multicenter randomized clinical trial.
PMID 42370999 — mortality, blood, blood pressure, critical care, kidney, therapeutics, intensive care units, acute kidney injury		Intensive Care Med20263
Impact of appropriate antimicrobial therapy on patient outcomes and antimicrobial use: a sub analysis of the DIANA Study Dataset.
PMID 42228012 — mortality, critical care, critical illness, therapeutics, intensive care units, infections		Intensive Care Med20260

Clinical Studies 19

Sources: ClinicalTrials, EU CTIS

Synthesis

Principal Investigator: 2 Study Director: 1

By phase:

N/A 9
Phase 3 7
Phase 4 2
Phase 2 1

By status:

Completed 7
Unknown 5
Recruiting 4
Terminated 2
Active not recruiting 1

By type:

Interventional 13
Observational 6

By Monocentric/Multicentric:

monocentric 12
multicentric2to4 3
multicentric5to9 1
multicentricup10 3

Main Topics

Cohort/Consortium Investigators 15

Ongoing Clinical Trials

3 ongoing trials started since 2021, where this expert is an investigator

Source: ClinicalTrials

Study Phase Status Start
Efficacy and safety of adjunctive IgM enriched immunoglobulin therapy with a personalized dose based on serum IgM titers vs standard dose in patients with septic shock A multicenter interventional randomized single blinded two arms adaptive study design
2024-518096-57-00 — safety, serum, shock, septic, immunoglobulins, therapeutics		Phase 3Recruiting2024
Conservative vs conventional oxygen administration in critically ill patients effects on ICU mortality A multicentre randomized open label clinical trial
2024-518092-62-00 — mortality, critical illness, intensive care units, ventilation		Phase 3Recruiting2024
HAP VAP Diagnosis in Critically Ill Septic Patients Using a Multiplex PCR Array
NCT05952648 — healthcare-associated pneumonia, blood, agar, bronchoalveolar lavage, pneumonia, ventilator-associated, multiplex polymerase chain reaction, pneumonia, critical illness, diagnosis, lightning, veins		N/AActive not recruiting2024

LeadR Networks

Main global connection map

Sources: PubMed, OpenAlex, ClinicalTrials, EU CTIS